If you go back to past 2a trials for the HCV drugs you will see big gains from 2a results .
The new timetable .
http://www.informedhorizons.com/hepdart2011/pdf/Program_HEPDART2011_web.pdf
Our presentation is Tuesday 6th December 2011 . 10:10 am Hawaii time ( 5.40am CST next Wednesday ).
" Antiviral activity and tolerability of BIT225 plus pegylated interferon alpha 2a or 2b and weight-based ribavirin for 28 days in HCV treatment-naïve monoinfected patients .
( by Tawesak Tanwandee, Siriraj Hospital/Mahidol University, Thailand ) .
Our Professor R. Murphy is the Chairperson .
location/location/location, page-28
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $7.664K | 403.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1202498 | 5 |
View Market Depth
| Last trade - 13.42pm 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |